Background Evidence for the long-term use of antiplatelet drugs to prevent hepatic vascular
complications (HVC) is scarce in liver transplantation (LT). Methods From national claim …

To ascertain whether postoperative antiplatelet therapy could reduce the incidence of
hepatic artery thrombosis (HAT) after liver transplantation (LT), 838 consecutive adult whole …

Hepatic artery thrombosis (HAT) is the most serious vascular complication after liver
transplantation. Multiple risk factors have been identified to impact its development …

Both immediate and delayed thrombotic complications occur frequently following orthotopic
liver transplantation (OLT). 1 Thrombosis of the hepatic artery occurs in between 1.6% and …

Background A key tenet of clinical management of patients post liver transplantation (LT) is
the prevention of thrombotic and bleeding complications. This systematic review …

AIM: To identify risk factors that might contribute to hepatic artery thrombosis (HAT) after liver
transplantation (LT). METHODS: The perioperative and follow-up data of a total of 744 liver …

Little is known about nonsurgical risk factors for hepatic artery thrombosis (HAT) after liver
transplantation (LT). We determined risk factors for HAT occurring within 90 days post‐LT …

Aspirin used in the post-operative period as prophylaxis for hepatic artery thrombosis (HAT)
increases the risk of neurological complications (NC) in adult living donor liver …

Background. The impact of advanced donor age on hepatic artery thrombosis (HAT) after
liver transplantation (LT) is controversial. Methods. We analyzed the incidence of and risk …

Introduction Portal vein thrombosis (PVT) is a relatively common finding in patients
undergoing liver transplantation. Although the recommendation to prevent its recurrence is …